Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight DLA TROOP SUPPORT (SPE2DR) is its largest buyer. See more on the Buyers tab
About
From the company's SBA profile, updated Feb 2026
DMS is a full-line, woman-owned pharmaceutical wholesaler serving the brand and generic drug needs of nationwide customers: hospitals, closed pharmacies, long-term care facilities, and surgery centers.
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $299M in FY2025. See more on the Contracts tab
$2.52M since award = $1.49B in FY2021–FY2026 − $1.49B net corrections before FY2021
Click a state to open its page.
Insight 100% was performed in Illinois. See more on the Contracts tab
Contracts
224,134 contracts with an action since FY2021
Click a tile to open its contract.
Insight SPE2DR25D9331 orders hold 12% of these contracts' obligations.
Click a bar to open its industry page.
Insight 85% under NAICS 424210.
Current end date of the 400 most recently active of its 224,134 prime contracts with an action since FY2021
Hover over a month to see its value.
DMS Pharmaceutical Group Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–10 of the first 400 of 224,134 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| SPE2DR26FQRB9 | SPE2DR25D9331 | DLA TROOP SUPPORT (SPE2DR) | $157,348 | Jul 7, 2026 | Ended |
| SPE2DR26FQRB6 | SPE2DR25D9331 | DLA TROOP SUPPORT (SPE2DR) | $98,116 | Jul 2, 2026 | Ended |
| SPE2DR26FSCU2 | SPE2DR25D9316 | DLA TROOP SUPPORT (SPE2DR) | $94,753 | Jul 2, 2026 | Ended |
| SPE2DR26FSRC4 | SPE2DR25D9348 | DLA TROOP SUPPORT (SPE2DR) | $87,456 | Jul 6, 2026 | Ended |
| SPE2DR26FDAK3 | SPE2DR25D9127 | DLA TROOP SUPPORT (SPE2DR) | $76,545 | Jul 7, 2026 | Ended |
| SPE2DR26FDEZ8 | SPE2DR25D9112 | DLA TROOP SUPPORT (SPE2DR) | $64,275 | Jun 15, 2026 | Ended |
| SPE2DU26FEMZF | SPE2DU25D9517 | DLA TROOP SUPPORT (SPE2DU) | $47,987 | Jun 15, 2026 | Ended |
| SPE2DR26FHLJ5 | SPE2DR25D9222 | DLA TROOP SUPPORT (SPE2DR) | $46,211 | Jul 6, 2026 | Ended |
| SPE2DU26FEMZJ | SPE2DU25D9517 | DLA TROOP SUPPORT (SPE2DU) | $44,944 | Jun 16, 2026 | Ended |
| SPE2DR26FQXH6 | SPE2DR25D9353 | DLA TROOP SUPPORT (SPE2DR) | $42,631 | Jul 7, 2026 | Ended |
Buyers
Defense Logistics Agency: $2.52M obligated since award; $1.32B in FY2021–FY2025 actions
Click a bar to open its office page.
Insight Defense Logistics Agency placed 100%.
Contracting offices that awarded DMS Pharmaceutical Group prime contracts, FY2021–FY2026
See which offices award its contracts.
0 offices awarded only one contract.
Showing 1–5 of 5 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| DLA TROOP SUPPORT (SPE2DR) | Defense Logistics Agency | 258 | $2,142,677 | Jun 9, 2026 | Jun 13, 2026 |
| DLA TROOP SUPPORT (SPE2DU) | Defense Logistics Agency | 24 | $237,518 | Jun 10, 2026 | Jun 12, 2026 |
| DLA TROOP SUPPORT (SPE2DP) | Defense Logistics Agency | 87 | $131,334 | Apr 28, 2025 | Jun 13, 2026 |
| DLA TROOP SUPPORT (SPE2D3) | Defense Logistics Agency | 11 | $11,084 | Jun 9, 2026 | Jun 10, 2026 |
| DLA TROOP SUPPORT (SPE2D2) | Defense Logistics Agency | 20 | $708 | Jun 9, 2026 | Jun 13, 2026 |
Opportunities
Open opportunities matching DMS Pharmaceutical Group Inc.'s registered industries
Notices in its 3 industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325412, 423450, 424210
7 of the next 10 are due within 30 days.
Showing 1–10 of 10 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 21, 2026 |
| Inhaled Nitric Oxide (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (HT9408) | Oct 22, 2026 |
| Methylphenidate ER (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Oct 23, 2026 |
| Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (DHA) (HT0040) | Oct 26, 2026 |
| 6505--Imatinib Tablets (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 30, 2026 |
| LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNATIONAL CMOP OFFICE (36C770) | Nov 3, 2026 |
| Epinephrine Injector (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Nov 16, 2026 |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC FEDERAL SUPPLY SCHEDULE (36F797) | Nov 20, 2026 |
| DLA Medical Equipment Electronic CATalog (ECAT) Generation V Program (opens in Procura)Combined Synopsis/Solicitation · NAICS 423450Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2DH) | Dec 1, 2026 |
| TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of EnergyOffice 899015 | Dec 4, 2026 |
Registration and contacts
Registration
- UEI
- PX72BSBQTKJ3
- CAGE code
- 1UNB0
- Registration
- Active, expires Feb 23, 2027
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- PARK RIDGE, IL, 60068
- Congressional district
- IL-09
- Established
- 1995
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 3 industries; primary 424210
Contacts at DMS Pharmaceutical Group Inc.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Company contactSBA profileAs of Oct 4, 2026 | Oct 4, 2026 |
Correct this listing
Tell us what to correct or add on the DMS Pharmaceutical Group Inc. page. We check every request before we change a profile.